54 unchanged sentences
001-36365, and incorporated by reference here).
−Removed: Registration Rights Agreement, dated April 10, 2020, between SCYNEXIS, Inc.
−Removed: and Aspire Capital Fund, LLC (Filed with the SEC as Exhibit 4.1 to our Current Report on Form 8-K, filed with the SEC on April 13, 2020, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
Form of Indemnity Agreement between the Registrant and its directors and officers.
3 unchanged sentences
SCYNEXIS, Inc.
−Removed: Stock Option Plan, as amended and restated.
−Removed: (Filed with the SEC as Exhibit 10.1 to our Quarterly Report on Form 10-Q, filed with the SEC on August 10, 2020, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Stock Option Exercise under the SCYNEXIS, Inc.
−Removed: Stock Option Plan, as amended and restated.
−Removed: (Filed with the SEC as Annex B to our Proxy Statement on Schedule 14A, filed with the SEC on August 1, 2014, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: SCYNEXIS, Inc.
−Removed: 2009 Stock Option Plan, as amended and restated.
−Removed: (Filed with the SEC as Exhibit 10.2 to our Quarterly Report on Form 10-Q, filed with the SEC on August 10, 2020, SEC File No.
−Removed: 333-194192, and incorporated by reference here).
−Removed: Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Stock Option Exercise under the SCYNEXIS, Inc.
−Removed: 2009 Stock Option Plan, as amended and restated.
−Removed: (Filed with the SEC as Exhibit 10.3 to our Amendment No.
−Removed: 1 to Registration Statement on Form S-1, filed with the SEC on March 19, 2014, SEC File No.
−Removed: 333-194192, and incorporated by reference here).
−Removed: SCYNEXIS, Inc.
2014 Equity Incentive Plan, as amended and restated, (Filed with the SEC as Exhibit 10.3 to our Quarterly Report on Form 10-Q, filed with the SEC on August 10, 2020, SEC File No.
53 unchanged sentences
001-36365, and incorporated by reference here).
−Removed: Non-Employee Director Compensation Policy
−Removed: Senior Convertible Note Purchase Agreement, dated as of March 7, 2019, among SCYNEXIS, Inc., as Issuer, Puissance Capital Management, as the Investor (Filed with the SEC as Exhibit 10.1 to our current report on Form 8-K filed with the SEC on March 8, 2019, SEC File No 001-36365 and incorporated by reference here).
−Removed: Common Stock Purchase Agreement, dated April 10, 2020, between SCYNEXIS, Inc.
−Removed: and Aspire Capital Fund, LLC (Filed with the SEC as Exhibit 10.1 to our Form 8-K, filed with the SEC on April 13, 2020, SEC File No.
+Added: Non-Employee Director Compensation Policy (Filed with the SEC as Exhibit 10.2 to our Form 10-Q, filed with the SEC on May 8, 2024, SEC File No.
001-36365, and incorporated by reference here) .
+Added: Senior Convertible Note Purchase Agreement, dated as of March 7, 2019, among SCYNEXIS, Inc., as Issuer, Puissance Capital Management, as the Investor (Filed with the SEC as Exhibit 10.1 to our current report on Form 8-K filed with the SEC on March 8, 2019, SEC File No 001-36365 and incorporated by reference here).
Fourth Amendment to Termination and License Agreement between SCYNEXIS, Inc.
6 unchanged sentences
001-36365, and incorporated by reference here).
−Removed: Master Services Agreement, effective as of February 4, 2021, by and between SCYNEXIS, Inc.
−Removed: and Amplity, Inc.
−Removed: (Filed with the SEC as Exhibit 10.2 to our Form 10-Q, filed with the SEC on May 17, 2021, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
Loan and Security Agreement, dated May 13, 2021, among the Company, Hercules Capital Inc., and Silicon Valley Bank (Filed with the SEC as Exhibit 10.1 to our Form 10-Q, filed with the SEC on August 16, 2021, SEC File No.
4 unchanged sentences
001-36365, and incorporated by reference here).
−Removed: Controlled Equity Offering SM Sales Agreement, dated May 17, 2021, between SCYNEXIS, Inc.
−Removed: and Cantor Fitzgerald & Co.
−Removed: (Filed with the SEC as Exhibit 1.1 to our Current Report on Form 8-K, filed with the SEC on May 18, 2021, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Controlled Equity Offering SM Sales Agreement, dated May 17, 2021, between SCYNEXIS, Inc.
−Removed: and Ladenburg Thalmann & Co.
−Removed: (Filed with the SEC as Exhibit 1.2 to our Current Report on Form 8-K, filed with the SEC on May 18, 2021, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Employment Agreement, dated February 5, 2015, between SCYNEXIS, Inc.
−Removed: Marco Taglietti.
−Removed: (Filed with the SEC as Exhibit 10.27 to our Annual Report on Form 10-K, filed with the SEC on March 30, 2015, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Amendment of Employment Agreement, effective April 18, 2016, between SCYNEXIS, Inc.
−Removed: and Marco Taglietti.
−Removed: (Filed with the SEC as Exhibit 10.2 to our Quarterly Report on Form 10-Q, filed with the SEC on May 9, 2016, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Separation Agreement, dated October 20, 2022, between SCYNEXIS, Inc.
−Removed: and Marco Taglietti.
−Removed: (Filed with the SEC as Exhibit 10.38 to our Form 10-K, filed with the SEC on March 31, 2023, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
−Removed: Employment Agreement, dated May 10, 2021, between SCYNEXIS, Inc.
−Removed: and Christine Coyne (Filed with the SEC as Exhibit 10.1 to our Annual Report on Form 10-Q, filed with the SEC on May 12, 2022, SEC File No.
−Removed: 001-36365, and incorporated by reference here).
Employment Agreement, dated January 1, 2023, between SCYNEXIS, Inc.
13 unchanged sentences
Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between GlaxoSmithKline Intellectual Property (No.
−Removed: 3) Limited, and the Company.
−Removed: Separation Agreement, dated October 20, 2022, between SCYNEXIS, Inc.
−Removed: and Christine Coyne (Filed with the SEC as Exhibit 10.3 to our Form 10-Q with the SEC on May 10, 2023, SEC File No.
+Added: 3) Limited, and the Company (Filed with the SEC as Exhibit 10.41 to our Form 10-K with the SEC on March 28, 2024, SEC File No.
001-36365, and incorporated by reference here).
+Added: Employment Agreement, dated November 15, 2017, between SCYNEXIS, Inc.
+Added: and Scott Sukenick (Filed with the SEC as Exhibit 10.1 to our Form 10-Q, filed with the SEC on May 8, 2024, SEC File No.
+Added: 001-36365, and incorporated by reference here).
+Added: SCYNEXIS, Inc.
+Added: 2024 Equity Incentive Plan.(Filed with the SEC as Exhibit 99.1 to our Form S-8, filed with the SEC on June 20, 2024, SEC File No.
+Added: 333-280328, and incorporated by reference here).
+Added: Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the SCYNEXIS, Inc.
+Added: 2024 Equity Incentive Plan (Filed with the SEC as Exhibit 99.2 to our Form S-8, filed with the SEC on June 20, 2024, SEC File No.
+Added: 333-280328, and incorporated by reference here).
+Added: Forms of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the SCYNEXIS, Inc.
+Added: 2024 Equity Incentive Plan (Filed with the SEC as Exhibit 99.3 to our Form S-8, filed with the SEC on June 20, 2024, SEC File No.
+Added: 333-280328, and incorporated by reference here) .
+Added: Insider Trading Policy
Consent of Independent Registered Public Accounting Firm.
4 unchanged sentences
Section 1350 as Adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Incentive Compensation Recoupment Policy
+Added: Incentive Compensation Recoupment Policy (Filed with the SEC as Exhibit 97.1 to our Form 10-K with the SEC on March 28, 2024, SEC File No.
+Added: 001-36365, and incorporated by reference here).
Inline XBRL Instance Document
47 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.